APA (7th ed.) Citation

R, R., AM, T., SK, L., AT, A., LS, G., R, G., . . . MT, S. (2026). Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes. European urology oncology, 9(2), 430. https://doi.org/10.1016/j.euo.2025.01.002

Chicago Style (17th ed.) Citation

R, Raychaudhuri, et al. "Association of Prior PARP Inhibitor Exposure with Clinical Outcomes After 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes." European Urology Oncology 9, no. 2 (2026): 430. https://doi.org/10.1016/j.euo.2025.01.002.

MLA (9th ed.) Citation

R, Raychaudhuri, et al. "Association of Prior PARP Inhibitor Exposure with Clinical Outcomes After 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes." European Urology Oncology, vol. 9, no. 2, 2026, p. 430, https://doi.org/10.1016/j.euo.2025.01.002.